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Abstract 
Objectives 
To evaluate how age-related trends in nutritional status, physical health and parental well-
being in Rett syndrome may be related to gastrostomy placement, and to examine the impact 
of the procedure on mortality. 
Study design 
We included 323 females from the Australian Rett Syndrome Database and analyzed their 
demographic, genetic and child and parental health data collected from over six waves of 
follow-up questionnaire between 2000 and 2011. We used mixed-effects models to estimate 
the association between repeated measures of outcomes and age, gastrostomy placement and 
their interaction, and Cox proportional hazards regression models to estimate relative risks of 
mortality for individuals with gastrostomy. 
Results 
Nearly a third (30.3%) of the cases underwent gastrostomy placement. Nutritional status 
based on weight, height, and body mass index (BMI) improved over time, and BMI was 
greater in individuals with gastrostomy placement than in those without (adjusted beta 0.9, 
95% CI 0.0-1.7). There was no association between gastrostomy placement and individual’s 
physical health outcomes or parental physical and mental health, nor did the age trend of 
these outcomes vary by gastrostomy insertion status. Nevertheless, among those at risk of 
sub-optimal weight, all-cause mortality rate was higher in those who had gastrostomy 
placement group compared with those who had not (hazard ratio 4.1, 95% CI 2.0-8.5). 
Conclusion 
Gastrostomy placement was associated with improvement in BMI in females with Rett 
syndrome, but its long-term impact on individuals and their families is unclear.  
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Introduction 
Rett syndrome (RTT) is a rare but severe neurodevelopmental disorder mainly seen in 
females.1 The estimated incidence is 1 in 8,500 female births.2  It is associated with severe 
disability and there is no specific treatment or cure. Until recently, epidemiological and 
outcome data have been relatively sparse. 
The main diagnostic criteria of classical RTT now include: a history of partial or 
complete loss of acquired purposeful hand skills; a history of loss of acquired spoken 
language; impairment or inability to walk; and the presence of stereotypic hand movements.3 
Comorbidities include scoliosis, poor growth, osteoporosis, epilepsy, breathing abnormalities 
and sleep difficulties.4 In 1999, a causal association was identified between RTT and 
mutations in the methyl CpG binding protein 2 (MECP2) gene,5 and now more than 500 
disease-causing MECP2 mutations have been reported.6 
Feeding difficulties and poor growth are commonly seen in RTT and may be 
associated with poor oro-motor function, limited self-feeding skills, gastro-esophageal reflux 
disease, breathing dysfunction and constipation.7-9 There is a progressive decline in height, 
weight, and body mass index with age, likely influenced by genotype.10, 11 Gastrostomy 
feeding tube placement is a therapeutic option for addressing feeding difficulties and poor 
nutritional status. To date, its effectiveness in RTT has only been studied in a US clinic-based 
series where the outcomes assessed were limited to anthropometric data without 
consideration of other aspects of quality of care such as child and parental well-being.12 In 
keeping with the quality of care literature13 and recent recommendations relating to the 
assessment of gastrostomy outcomes14, the aims of this study were to 1) investigate age-
related trends in nutritional status, physical health and parental well-being in individuals with 
RTT, and 2) to evaluate how these changes may be related to gastrostomy placement. We 
also examined the impact of gastrostomy on mortality. 
  4 
Methods 
Study design and setting 
Established in 1993, the Australian Rett Syndrome Study began recruiting individuals 
with RTT from cases identified through the Australian Paediatric Surveillance Unit, the Rett 
Syndrome Association of Australia and other sources,15 including clinicians who manage the 
three specialized Rett syndrome clinics in Sydney, Melbourne, and Perth. At the core of the 
current study is the Australian Rett Syndrome Database, which stores demographic, genetic 
and health data on individuals with RTT at the time of recruitment, as well as responses from 
parents/caregivers to follow-up questionnaires that have been administered to primary 
caregivers since 1996. From 2000 onwards, questionnaires have included measures of 
functional ability; behavior and hand function; information on medical conditions; episodes 
of illness; use of health, therapy, respite and day-care services; feeding; equipment use; and 
education. From 2002 onwards, questionnaires have also included measures of family 
functioning and health and well-being of the primary caregiver (e.g., parents). Seven waves 
of follow-up questionnaires (1996, 2000, 2002, 2004, 2006, 2009 and 2011) have been 
distributed. Pertinent clinical data, including data recorded during inpatient care and 
outpatient attendance, were extracted from medical records to enrich the dataset captured by 
the questionnaire. 
Ethics approval for data collection was provided by the Human Research Ethics 
Committee of Princess Margaret Hospital for Children, Perth (1909/EP); Royal Perth 
Hospital, Perth (RA-12/007); Women’s and Children’s Hospital, Adelaide 
(HREC/13/WCHN/57); Royal Children’s Hospital, Melbourne (31339A); Monash Medical 
Centre, Melbourne (14203Q); Sydney Children’s Hospitals Network, Sydney (LNR-2011-10-
13); Mater Children’s Hospital, Brisbane (1878/LNR); and Royal Children’s Hospital, 
Brisbane (HREC/12/QRCH/76). Ethics approval was also obtained to link the cohort to the 
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National Death Index administered by the Australian Institute of Health and Welfare 
(EC380). All families provided informed consent before participating. The study design can 
be considered as a single cohort, multiple age design, a variant of the cross-sequential 
longitudinal design.16 
Study participants 
Females with a clinically or genetically confirmed diagnosis of RTT, whose 
parents/caregivers had completed at least one follow-up questionnaire from 2000, were 
included in the study. Health outcomes, including individuals’ anthropometric and physical 
health data, were collected from questionnaires in 2000, 2002, 2004, 2006, 2009 and 2011 
and hospital records, whilst data on parental well-being outcomes were gathered from 
questionnaires in 2002, 2006, 2009 and 2011. For health outcomes, 323 individuals with RTT 
were eligible for the study. The number of questionnaires completed ranged from one to six 
with a median of three. A total of 88 parents/caregivers completed all six waves of 
questionnaires, 47 had completed five, 44 four, 40 three, 53 two and 51 one. Therefore, a 
total number of 1,216 responses were available for 323 individuals. For parental well-being 
outcomes, parents/caregivers of 311 individuals completed at least one of the four waves of 
questionnaires. The number of questionnaires completed ranged from two to four per patient 
with a median of two. A total of 116 parents/caregivers had completed all four 
questionnaires, 70 completed three, 57 completed two and 68 completed one. The total 
numbers of individuals and responses were 311 and 856 respectively. 
Variable definitions 
Weight (kg) and height (cm) data were provided by parents/caregivers in the follow-
up questionnaires, in addition to those ascertained from medical records. Body mass index 
(BMI) (kg/m2) was calculated as weight divided by height squared. Parental well-being was 
measured using the 12-Item Short-Form Health Survey (SF-12) Physical Component 
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Summary (PCS) and Mental Component Summary (MCS) scales, with higher scores 
representing better health.17 The PCS domains are named as follows: “Physical Functioning”, 
“Role-physical”, “Bodily Pain”, and “General Health”, whilst the MCS domains are 
“Vitality”, “Social Functioning”, “Role-emotional” and “Mental Health”. The instrument was 
included in the 2002, 2006, 2009 and 2011 follow-up questionnaires and was answered by 
either parent of the individual. The PCS and MCS scores have been shown to be valid in 
Australian and other populations.18, 19 Using the population mean item weight method, data 
with up to three of the six key items (i.e., items that contribute predominantly to a given 
score) missing and any number of non-key items missing for either PCS or MCS were 
imputed.20 Total number of illness episodes was defined as the sum of the reported number of 
upper (e.g., cold, ear infection, tonsillitis) and lower (e.g., bronchitis, pneumonia) respiratory 
infections experienced by the individual in the 12 months prior to completion of each follow-
up questionnaire. Cumulative length of hospital stay was defined as the sum of reported 
number of days in hospital being admitted for respiratory tract infections, seizures or 
gastrointestinal problems in the 12 months prior to completion of the follow-up 
questionnaire. 
Gastrostomy placement was defined by whether the intervention had been reported at 
the time of the follow-up questionnaire completion and was coded as a binary variable: 
Yes/No. Other variables included in the analysis were age at completion of each 
questionnaire centered around overall median value of 15 years, MECP2 gene mutation type, 
feeding method, mobility, ever learned to walk, sleep disturbances, scoliosis and breath 
holding. Family variables included in the analysis were residence, type of respondent, 
respondent’s age, respondent’s work status, respondent’s highest level of education, use of 
formal respite care, household annual income, geographic remoteness of parental home, and 
socio-economic status of parental household based on the Index of Relative Socio-economic 
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Advantage and Disadvantage (IRSAD)21 with lower scores representing disadvantaged 
(<50%) and higher scores representing advantaged areas (>=50%). The “in care” subgroup 
comprises females who were no longer living in the family home. 
Statistical analysis 
Cross-sectional descriptive statistics, reported as mean (SD), median (range) or n (%) 
where appropriate, were used to summarize the outcomes, exposure, and all 
explanatory/confounding variables. Two generalized linear mixed-effects models were used 
to investigate the effect of individual’s age on the nutritional status, physical health and 
parental well-being outcomes (Model 1) and their relationship to gastrostomy placement 
(Model 2). Main effects of age at questionnaire completion, questionnaire year, and pertinent 
explanatory/confounding variables were included in both models. Model 2 also included the 
main effect of gastrostomy placement and an interaction term between age at questionnaire 
completion and gastrostomy placement, and the sample was limited to individuals with sub-
optimal weight which was defined as ever having a weight-for-age z-score (WAZ) of less 
than -1 at time of questionnaire completion during the follow-up period. Such restriction was 
applied so the benefits or otherwise of gastrostomy placement on the outcomes would be 
better understood in individuals who were likely to receive the procedure. The z-score was 
calculated using the 2000 Centers for Disease Control and Prevention growth reference for 
the United States.22 For both models, linear age effect was examined for all outcomes while 
quadratic age effect was investigated only for anthropometric measures. All outcomes were 
treated as continuous variables except illness episodes and length of stay which were treated 
as count variables. Choice of explanatory/confounding variables was guided by a priori 
knowledge of associations with outcomes as well as the exposure of interest. Unadjusted and 
adjusted estimates of the fixed effects and their 95% confidence intervals were reported. 
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For survival analysis, individuals with a WAZ < -1 during the follow-up period, were 
included in the analysis. Individuals became at risk at birth and entered the study at time of 
first recorded low weight-for-age z-score (to account for left truncation as individuals might 
have died prior to recruitment). Follow-up time was censored at the end of the observation 
period, which was defined as the earliest of the following: date of death or 31st Dec 2014 (to 
account for right censoring as death has not yet been observed during the follow-up period). 
The Kaplan–Meier method was used to estimate the survival function for the whole group 
and also for those who had never had gastrostomy. After splitting the follow-up time at age at 
first gastrostomy placement, a Cox proportional hazards model was fitted with a time-varying 
variable to indicate whether individuals have undergone the intervention. Hazard ratio for 
gastrostomy placement, adjusted for mutation type and learned to walk status, was estimated. 
Choice of adjustment covariates was guided by their relevance as severity indicators. The 
proportional hazards assumption was tested and confirmed using the Schoenfield residuals. 
The crude and adjusted hazard ratios and their 95% confidence intervals were presented. 
All analyses were carried out in Stata 14.2 (StataCorp LP, College Station, TX). 
Results 
Characteristics of 323 females with RTT and their families by questionnaire year are 
shown in Table 1 and Table 2. The median age at questionnaire completion increased from 
13 years (range 1-24 years) in 2000 to 17 years (range 2-35 years) in 2011. Close to a third 
(30.3%, n=98) of the study population underwent gastrostomy placement. The prevalence of 
gastrostomy placement increased by questionnaire year from 11.9% in 2000 to 27.0% in 
2011, although most of the rise occurred between 2000 and 2006. The median recruitment 
age dropped slightly from 7 years (range 1-18 years) to 5 years (range 1-24 years) over the 
decade. By calendar year, there were gains in mean weight, height, and BMI over the 10 
years from 2000, and the mean MCS score improved between 2002 and 2011 (Table 3). On 
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the other hand, the average PCS score and the total number of illness episodes remained 
relatively stable. The mean cumulative length of stay varied with no discernible trend. 
Longitudinal data analysis 
WEIGHT, HEIGHT AND BMI. After accounting for pertinent covariates, weight, 
height and BMI increased with age (weight: adjusted age  1.33, 95% CI 1.16,1.50, P-value 
<0.01; height: adjusted age  1.87, 95% CI 1.72,2.02, P-value <0.01; BMI: adjusted age  
0.29, 95% CI 0.22,0.36, P-value <0.01). BMI, specifically, was higher in those with 
gastrostomy placement compared to those without gastrostomy (weight: adjusted  1.46, 95% 
CI -0.21,3.13, P-value 0.09; height: adjusted  -0.63, 95% CI -3.05,1.80, P-value 0.61; BMI: 
adjusted  0.87, 95% CI 0.02,1.73, P-value 0.04) (Table 4). Overall, the age trend of weight, 
height and BMI did not differ by gastrostomy placement status (Table 4). 
ILLNESS EPISODES. For the average female with RTT, the incidence of illness 
decreased with age (adjusted incidence rate ratio (IRR) 0.95, 95% CI 0.94,0.96, P-value 
<0.01). There was no evidence to suggest that gastrostomy placement was associated with 
increased incidence of illness for a typical female (adjusted IRR 1.06, 95% CI 0.87,1.29, P-
value 0.57), and the age trend of illness episodes was not affected by gastrostomy placement 
(adjusted IRR 1.02, 95% CI 0.99,1.04, P-value 0.18) (Table 4). 
LENGTH OF HOSPITAL STAY. Average cumulative length of hospital stay of any 
female with RTT did not change with age (adjusted IRR 0.97, 95% CI 0.93,1.02, P-value 
0.27). Similarly, gastrostomy placement was not associated with longer period of stay 
(adjusted IRR 2.08, 95% CI 0.86,5.04, P-value 0.11). The age trend of length of stay 
appeared to be similar before and after gastrostomy placement (adjusted IRR 0.94, 95% CI 
0.84,1.05, P-value 0.24) (Table 4). 
PARENTAL PHYSICAL COMPONENT SUMMARY (PCS). No age effect on PCS 
score was observed after accounting for pertinent covariates (adjusted  -0.14, 95% CI -
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0.36,0.08, P-value 0.21). Gastrostomy placement was not related to parental physical health 
(adjusted  -0.45, 95% CI -3.08,2.19, P-value 0.74) (Table 4). Similarly, there was no 
evidence of an age trend of the score in females with gastrostomy placement compared to 
those without (adjusted  -0.11, 95% CI -0.45,0.23, P-value 0.53) (Table 4). 
PARENTAL MENTAL COMPONENT SUMMARY (MCS). Similar to that of PCS, no 
age effect on the MCS score was observed among parents (adjusted  -0.06, 95% CI -
0.30,0.17, P-value 0.59). The score did not differ by gastrostomy placement status (adjusted 
 -1.25, 95% CI -4.25,1.75, P-value 0.41) (Table 4). In addition, having gastrostomy did not 
appear to affect the age-related trend of MCS score (adjusted  -0.10, 95% CI -0.51,0.30, P-
value 0.63) (Table 4). 
Survival analysis 
Characteristics of the 233 females with a weight-for-age z-score of less than -1 are 
shown in Table 5 (online). Among them, 83 (35.6%) individuals had had gastrostomy 
placement. The median age of the first gastrostomy placement was 9 years (range 1-35 
years). Reported feeding difficulties, an indicator of oropharyngeal capabilities and was 
defined as need for special food preparation and/or observed coughing/choking when being 
fed liquid or soft food, were common (69.6%) among females who never had had 
gastrostomy but somewhat higher (86.4%) in those who did go on to have a gastrostomy. The 
estimated survival probability was 73.5% (95% CI 46.3%,88.4%) at 15 years of age and 
66.1% (95% CI 43.5%,81.3%) at 20 years of age (median survival time 33 years 8 months) 
based on 47 deaths over a total observation time of 2,207 person-years. When observation 
period related to gastrostomy placement was removed (the censor age was replaced with the 
age at first procedure), the estimated probability of survival in those who had not had the 
intervention was 91.3% (95% CI 76.1%,97.0%) and 87.3% (95% CI 73.4%,94.2%) at 15 and 
20 years, respectively. After adjusting for mutation type and learned to walk status, the all-
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cause mortality rate was higher in the gastrostomy group compared with the group who never 
had gastrostomy placement (adjusted hazard ratio 4.07, 95% CI 1.96,8.45, P-value <0.01). 
Among the deceased who had had gastrostomy placement (n=30), the median age at first 
procedure was 11 years (range 3-35 years) and the median duration from first gastrostomy to 
death was 6 years (range 1 month-20 years). 
Discussion 
Gastrostomy is a frequent intervention for children with severe disabilities and 
feeding difficulties. In RTT it is used in nearly one-third of cases and, as we have shown, use 
has considerably increased since the turn of the century. The primary purpose of this study 
was to exploit a longitudinal, population-based database to investigate the effects of 
gastrostomy not only on nutritional status but also on other aspects of health, survival and 
parental well-being. Although BMI was higher in those with a gastrostomy, we could not 
demonstrate any positive age trend in parameters of nutritional status associated with 
gastrostomy insertion. Moreover, we did not find any beneficial effect of gastrostomy or an 
associated trend with age on illness episodes or length of hospital stay. Although we had 
hypothesized that there might be a reduction in hospitalizations associated with the use of 
gastrostomy, we found no evidence to support this. We also did not find any effect of 
gastrostomy on parental physical or mental health. 
To date there have only been two studies evaluating the effect of gastrostomy on 
anthropometric parameters before and after gastrostomy in RTT.12, 23 The first was 
undertaken on a convenience sample of 92 individuals with RTT followed clinically at the 
Texas Children’s Hospital.12 Weight (n=81), height (n=73), and BMI (n=81) z-score slopes 
increased post-gastrostomy compared with pre-gastrostomy with the highest increase seen in 
BMI and the least in height z-scores irrespective of the child’s age at surgery. Similar results 
were seen for fat-free mass and body fat although these results were only available for a 
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smaller number of individuals. The small number of cases precluded investigation by specific 
mutation type, and therefore mutations were grouped into categories, possibly obscuring any 
difference. The second study, using data from the Australian Rett Syndrome Database and 
published in 2014, has similarities to the US study but was limited to a comparison of weight-
for-age z-scores pre- and approximately two years post-gastrostomy.23 We found an increase 
in the z-score of, on average, 0.86 following gastrostomy.  
Our previous preliminary study was the impetus for the current study which now 
includes data on 323 individuals obtained from multiple questionnaire waves providing over 
1,200 observations relating to those with or without a gastrostomy. The extensive dataset has 
allowed us to investigate some of the risk and protective factors for nutritional status (Model 
1) in addition to addressing our primary research question, namely the impact of gastrostomy 
on nutritional status, physical health, parental well-being (Model 2) and mortality in those 
classified as having sub-optimal weight. As might also be expected nutritional status was 
shown to be most compromised in those unable to walk even after adjusting for genotype. 
Consistent with previous studies12, 23 we showed that, in individuals with sub-optimal 
weight, BMI was higher in those with gastrostomy insertion compared with the group who 
never had had gastrostomy. We could not confirm the positive effect on weight and height 
seen in the US study.12 Moreover, we did not identify a different or improved trajectory in 
these parameters following gastrostomy. It is possible therefore that the immediate impact of 
gastrostomy is an increase in overall nutritional status but afterward the trajectory continues 
as previously. Rett syndrome-specific growth trajectories have been developed but contain no 
indication of the proportion of children with a gastrostomy who were included in the sample 
or their impact on the growth curves.11 
Mortality rate was higher among individuals with RTT who received gastrostomy 
placement. There have been relatively few studies examining mortality in RTT because of the 
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absence of population-based and longitudinal data.  Aside from studies using the Australian 
Database,24-27 in one of which a protective effect of surgical fusion on mortality in severe 
scoliosis was demonstrated,27 the only other comparable investigation is the US Natural 
History Study in which 1,090 females with RTT were followed for up to nine years, during 
which time 41 died.28 In this study, low WAZ increased the risk of mortality.  
Ours has been the only study to investigate the impact of gastrostomy on the health 
and hospitalization pattern of individuals with RTT. We did not find that health outcomes 
were improved or hospitalization rate reduced after gastrostomy. These findings are 
consistent with a study which, through a retrospective review of 114 patients at Boston 
Children’s Hospital with an abnormal swallow on video fluoroscopy, found that thickened 
oral feeds were more effective in reducing the rate of hospitalization in children with 
aspiration than was gastrostomy.29 The authors recommended a trial of thickening of feeds 
before gastrostomy-tube placement in this population. Our results could also reflect more 
careful subsequent attention being given to the management of comorbid health conditions 
which might have been neglected before gastrostomy insertion. Alternatively, children 
selected for gastrostomy rather than the continuation of oral feeding might be those who had 
more comorbidities. Overall, illness episodes and hospitalizations, however, were relatively 
infrequent in our study population. 
We did not find any association between gastrostomy and the mental health of 
caregivers of gastrostomy recipients in the low weight group. These results were somewhat at 
odds with our earlier study in which families told us that after gastrostomy insertion they felt 
less anxious about the care of their child.23  In that study, most families noted a reduction in 
feeding difficulties, and coughing and choking and fatigue during feeding. They also agreed 
that their daughters were happier and had improved health and well-being and that 
medications were simpler to administer and the time taken to feed was shorter. It is possible 
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that the general nature of the parental well-being measures used in our current study was 
unable to capture the practical benefits of gastrostomy placement we had previously 
documented. 
There are many strengths to this study, a major one being the data source. The 
Australian Rett Syndrome Database, established in 1993, contains the only ongoing 
population-based data on this rare disorder and includes up to seven waves of longitudinal 
data collected since 1996.30 An additional strength is the comprehensive set of covariates, 
including genotype, which were available for inclusion in the analysis. Regarding limitations, 
there were missing data as a result of non-response or study attrition as contact was lost with 
some families. Other shortcomings relate to the completeness and self-reported nature of the 
anthropometric data, particularly the height variable which can be difficult to measure in this 
population, and the lack of standardized measures of nutritional status. Although we have 
taken into consideration pertinent confounders in our analyses, we acknowledge that females 
with RTT selected for gastrostomy placement, especially among those with a history of sub-
optimal weight, were more likely to be affected by co-morbidities (e.g., refractory epilepsy) 
which could have contributed to the observed results such as poorer survival outcome. Such 
confounding by indication is difficult to control in observational studies31 and cannot be 
entirely ruled out.  
As enteral feeding is being increasingly used in children and adults with RTT and 
other disorders, improving study designs and establishing uniform methods of measuring 
outcomes to allow for better synthesis of evidence are urgent priorities.14 While randomized 
controlled trials can be used to assess other types of nutritional interventions,32 for ethical 
reasons these are not an option for evaluating gastrostomy feeding either in RTT or in 
conditions such as cystic fibrosis,33 where enteral nutrition may have a role in improving 
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survival following later lung transplantation. We acknowledge that our outcome measures are 
incomplete, and we lack data on health costs. 
Although we have now demonstrated a beneficial impact of gastrostomy on 
nutritional status and previously on family satisfaction,23 we have not demonstrated a long-
term benefit for parental well-being, a reduction in hospitalizations following gastrostomy or 
a reduction in mortality. However, as changes in clinical practice occur as time progresses, it 
is possible that earlier gastrostomy insertion may be shown to have a more positive effect on 
growth, morbidity or mortality patterns. This supposition will be the subject of future 
research with more recently collected longitudinal data.  
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Abbreviations 
RTT  Rett syndrome 
MECP2 methyl CpG binding protein 2 
BMI  body mass index 
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PCS  Physical Component Summary 
MCS   Mental Component Summary 
IRSAD Index of Relative Socio-economic Advantage and Disadvantage 
IRR  incidence rate ratio
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Table 1. Characteristics of 323 females with Rett syndrome, by questionnaire year 
 
 Questionnaire year 
 2000 2002 2004 2006 2009 2011 
Number of questionnaire completed 159 187 201 209 223 237 
Had had gastrostomy 
placement, n (%) 
      
No 140 (88.1) 153 (81.8) 157 (78.1) 154 (73.7) 165 (74.0) 173 (73.0) 
Yes 19 (11.9) 34 (18.2) 44 (21.9) 55 (26.3) 58 (26.0) 64 (27.0) 
Age at first gastrostomy 
placement (years), median (range) 
9 (3-18) 10 (3-23) 9 (1-27) 9 (1-30) 9 (1-30) 9 (1-35) 
Age at questionnaire completion 
(years), median (range) 
13 (1-24) 13 (2-27) 15 (2-29) 15 (2-30) 18 (2-34) 17 (2-35) 
Mutation type, n (%)       
Large deletion 6 (3.8) 9 (4.8) 11 (5.5) 12 (5.7) 13 (5.8) 15 (6.3) 
Early truncation 10 (6.3) 13 (7.0) 11 (5.5) 11 (5.3) 12 (5.4) 13 (5.5) 
C-terminal deletion 14 (8.8) 15 (8.0) 18 (9.0) 20 (9.6) 23 (10.3) 25 (10.5) 
p.Arg106Trp 4 (2.5) 3 (1.6) 5 (2.5) 8 (3.8) 8 (3.6) 10 (4.2) 
p.Arg133Cys 8 (5.0) 10 (5.3) 11 (5.5) 11 (5.3) 18 (8.1) 19 (8.0) 
p.Thr158Met 14 (8.8) 16 (8.6) 16 (8.0) 17 (8.1) 18 (8.1) 21 (8.9) 
p.Arg168* 15 (9.4) 16 (8.6) 19 (9.5) 16 (7.7) 15 (6.7) 22 (9.3) 
p.Arg255* 7 (4.4) 7 (3.7) 10 (5.0) 11 (5.3) 15 (6.7) 13 (5.5) 
p.Arg270* 12 (7.5) 14 (7.5) 14 (7.0) 13 (6.2) 15 (6.7) 14 (5.9) 
p.Arg294* 10 (6.3) 12 (6.4) 16 (8.0) 16 (7.7) 15 (6.7) 14 (5.9) 
p.Arg306Cys 8 (5.0) 9 (4.8) 10 (5.0) 11 (5.3) 9 (4.0) 10 (4.2) 
Other 13 (8.2) 15 (8.0) 16 (8.0) 18 (8.6) 17 (7.6) 18 (7.6) 
Negative 38 (23.9) 48 (25.7) 44 (21.9) 45 (21.5) 45 (20.2) 43 (18.1) 
Feeding method, n (%)       
Oral 137 (86.2) 155 (82.9) 158 (78.6) 162 (77.5) 170 (76.2) 178 (75.1) 
Enteral 19 (11.9) 31 (16.6) 42 (20.9) 44 (21.1) 47 (21.1) 53 (22.4) 
Missing 3 (1.9) 1 (0.5) 1 (0.5) 3 (1.4) 6 (2.7) 6 (2.5) 
Mobility, n (%)       
Walks normally 26 (16.4) 54 (28.9) 47 (23.4) 49 (23.4) 60 (26.9) 69 (29.1) 
Walking impaired 34 (21.4) 52 (27.8) 53 (26.4) 48 (23.0) 57 (25.6) 63 (26.6) 
Cannot walk with support 97 (61.0) 81 (43.3) 98 (48.8) 108 (51.7) 105 (47.1) 96 (40.5) 
Missing 2 (1.3) 0 (0) 3 (1.5) 4 (1.9) 1 (0.4) 9 (3.8) 
Sleeping disturbances, n (%)       
None 14 (8.8) 20 (10.7) 21 (10.4) 47 (22.5) 58 (26) 88 (37.1) 
Sometimes 16 (10.1) 19 (10.2) 19 (9.5) 39 (18.7) 40 (17.9) 43 (18.1) 
Often 121 (76.1) 146 (78.1) 156 (77.6) 110 (52.6) 118 (52.9) 91 (38.4) 
Missing 8 (5) 2 (1.1) 5 (2.5) 13 (6.2) 7 (3.1) 15 (6.3) 
Scoliosis, n (%)       
None 71 (44.7) 75 (40.1) 71 (35.3) 72 (34.4) 78 (35) 74 (31.2) 
Mild 67 (42.1) 90 (48.1) 106 (52.7) 102 (48.8) 105 (47.1) 114 (48.1) 
Severe 7 (4.4) 7 (3.7) 6 (3.0) 13 (6.2) 11 (4.9) 11 (4.6) 
Surgically treated 12 (7.5) 15 (8.0) 17 (8.5) 20 (9.6) 28 (12.6) 31 (13.1) 
Missing 2 (1.3) 0 (0) 1 (0.5) 2 (1.0) 1 (0.4) 7 (3.0) 
Breath holding, n (%)       
None 44 (27.7) 38 (20.3) 52 (25.9) 61 (29.2) 75 (33.6) 73 (30.8) 
Sometimes 53 (33.3) 84 (44.9) 66 (32.8) 69 (33.0) 80 (35.9) 88 (37.1) 
Often 59 (37.1) 65 (34.8) 82 (40.8) 77 (36.8) 66 (29.6) 67 (28.3) 
Missing 3 (1.9) 0 (0) 1 (0.5) 2 (1) 2 (0.9) 9 (3.8) 
Note: Percentages of categories within variable may not add up to 100 due to rounding 
n, number of questionnaire completed; n, number of individuals 
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Table 2. Characteristics of the families of 323 females with Rett syndrome, by questionnaire year 
 
 Questionnaire year 
 2000 2002 2004 2006 2009 2011 
Number of questionnaire completed 159 187 201 209 223 237 
Place of residence, n (%)       
Parental home 0 (0) 174 (93) 167 (83.1) 171 (81.8) 181 (81.2) 188 (79.3) 
Group home/In care^ 0 (0) 10 (5.3) 33 (16.4) 36 (17.2) 42 (18.8) 44 (18.6) 
Missing 159 (100) 3 (1.6) 1 (0.5) 2 (1.0) 0 (0) 5 (2.1) 
Respondent, n (%)       
Natural mother 0 (0) 174 (93) 165 (82.1) 154 (73.7) 161 (72.2) 173 (73) 
Natural father 0 (0) 0 (0) 2 (1.0) 16 (7.7) 16 (7.2) 15 (6.3) 
Other including carer 0 (0) 10 (5.3) 33 (16.4) 37 (17.7) 46 (20.6) 44 (18.6) 
Missing 159 (100) 3 (1.6) 1 (0.5) 2 (1.0) 0 (0) 5 (2.1) 












Respondent's work status, n (%)       
Full time at home 0 (0) 63 (33.7) 78 (38.8) 82 (39.2) 73 (32.7) 86 (36.3) 
Full-time of part-time work 0 (0) 64 (34.2) 84 (41.8) 80 (38.3) 94 (42.2) 93 (39.2) 
In care^ 0 (0) 10 (5.3) 33 (16.4) 41 (19.6) 43 (19.3) 44 (18.6) 
Missing 159 (100) 50 (26.7) 6 (3.0) 6 (2.9) 13 (5.8) 14 (5.9) 
Respondent's highest level of education, n (%)       
Non-tertiary 0 (0) 67 (35.8) 84 (41.8) 86 (41.1) 80 (35.9) 80 (33.8) 
Tertiary 0 (0) 69 (36.9) 77 (38.3) 79 (37.8) 87 (39.0) 97 (40.9) 
In care^ 0 (0) 10 (5.3) 33 (16.4) 36 (17.2) 43 (19.3) 44 (18.6) 
Missing 159 (100) 41 (21.9) 7 (3.5) 8 (3.8) 13 (5.8) 16 (6.8) 
Respondent's use of 
formal respite care, n (%)       
None 0 (0) 99 (52.9) 125 (62.2) 34 (16.3) 37 (16.6) 42 (17.7) 
Any 0 (0) 75 (40.1) 36 (17.9) 126 (60.3) 130 (58.3) 136 (57.4) 
In care^ 0 (0) 10 (5.3) 33 (16.4) 36 (17.2) 43 (19.3) 44 (18.6) 
Missing 159 (100) 3 (1.6) 7 (3.5) 13 (6.2) 13 (5.8) 15 (6.3) 
Household income, n (%)       
<$50,000 0 (0) 89 (47.6) 82 (40.8) 76 (36.4) 67 (30.0) 57 (24.1) 
>=$50,000 0 (0) 53 (28.3) 52 (25.9) 59 (28.2) 77 (34.5) 80 (33.8) 
Prefer not to answer 0 (0) 32 (17.1) 33 (16.4) 36 (17.2) 32 (14.3) 47 (19.8) 
In care^ 0 (0) 10 (5.3) 33 (16.4) 36 (17.2) 43 (19.3) 44 (18.6) 
Missing 159 (100) 3 (1.6) 1 (0.5) 2 (1.0) 4 (1.8) 9 (3.8) 
Remoteness of parental home, n (%)       
Major Cities 92 (57.9) 106 (56.7) 111 (55.2) 114 (54.5) 125 (56.1) 130 (54.9) 
Regional or remote 66 (41.5) 71 (38.0) 57 (28.4) 59 (28.2) 56 (25.1) 63 (26.6) 
In care^ 0 (0) 10 (5.3) 33 (16.4) 36 (17.2) 42 (18.8) 44 (18.6) 
Missing 1 (0.6) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
Socio-economic status (IRSAD centile), n (%)       
<50% 58 (36.5) 65 (34.8) 47 (23.4) 45 (21.5) 59 (26.5) 63 (26.6) 
>=50% 100 (62.9) 112 (59.9) 120 (59.7) 127 (60.8) 122 (54.7) 130 (54.9) 
In care^ 0 (0) 10 (5.3) 33 (16.4) 36 (17.2) 42 (18.8) 44 (18.6) 
Missing 1 (0.6) 0 (0) 1 (0.5) 1 (0.5) 0 (0) 0 (0) 
Note: Percentages of categories within variable may not add up to 100 due to rounding 
* limited to natural mother or natural father of the individuals 
^ “In care” subgroup comprises females who were no longer living in the family home 
n, number of responses  
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Table 3. Descriptive statistics of nutritional status, physical health and parental well-being outcomes 
of females with Rett syndrome, by questionnaire year 
 
n, number of responses; SD, standard deviation 
 Questionnaire year  
 







159 187 201 209 223 237 323 
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Table 4. Effects of age, gastrostomy placement and their interaction on nutritional status, physical health and parental well-being outcomes in Rett 
syndrome females with suboptimal weight (weight-for-age z-score <-1) during the follow-up period 
 
 
Weight (kg) Height (cm) BMI (kg/m2) Total number of 
illness episodes 
Cumulative length 
of hospital stay (days) 
PCS score MCS score 
Number of individuals 173 173 173 172 173 110 110 
Number of observations 670 632 625 641 708 298 298 
 a 95% CI a 95% CI a 95% CI IRRa 95% CI IRRa 95% CI b 95% CI c 95% CI 
GASTROSTOMY 1.46 -0.21,3.13 -0.63 -3.05,1.80 0.87 0.02,1.73 1.06 0.87,1.29 2.08 0.86,5.04 -0.45 -3.08,2.19 -1.25 -4.25,1.75 
               
AGE 1.11 0.93,1.28 1.66 1.44,1.88 0.26 0.19,0.33 0.95 0.94,0.97 1.00 0.94,1.08 -0.21 -0.55,0.13 0.12 -0.23,0.46 
GASTROSTOMY X AGE 0.12 -0.08,0.32 0.10 -0.20,0.40 0.01 -0.10,0.12 1.02 0.99,1.04 0.94 0.84,1.05 -0.11 -0.45,0.23 -0.10 -0.51,0.30 
               
AGE2 -0.04 -0.06,-0.03 -0.13 -0.15,-0.12 0.004 -0.01,0.01         
GASTROSTOMY X AGE2 -0.02 -0.04,-0.004 0.04 0.01,0.07 -0.02 -0.03,-0.01         
               
a adjusted for mutation type, mobility, breath holding and socio-economic status 
b adjusted for mutation type, mobility, sleep disturbances, breath holding, residence, respondent’s age, respondent’s work status, respondent’s education level, household income and remoteness 
c adjusted for mutation type, mobility, sleep disturbances, scoliosis, residence, respondent’s age, respondent’s work status, respondent’s education level, household income and remoteness 
, coefficient; IRR, incidence rate ratio; CI, confidence interval; SES, socio-economic status; Ref, reference level; BMI, body mass index; PCS, physical component summary; MCS, mental component summary 
Coefficient represents the estimated difference in mean value (e.g. weight) compared to reference level of covariate; Incidence rate ratio represents the estimated relative difference in rate of outcome (e.g. cumulative 
length of hospital stay) compared to reference level of covariate 
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Table 5. Descriptive statistics of the 233 Rett syndrome females with a weight-for-age z-score of less 
than -1 during the follow-up period 
 





N 150 83 233 
Mutation type, n (%)    
Large deletion  9 (6.0)  7 (8.4)  16 (6.9) 
Early truncation  8 (5.3)  8 (9.6)  16 (6.9) 
C-terminal deletion  15 (10.0)  5 (6.0)  20 (8.6) 
p.Arg106Trp  7 (4.7)  3 (3.6)  10 (4.3) 
p.Arg133Cys  10 (6.7)  4 (4.8)  14 (6.0) 
p.Thr158Met  11 (7.3)  7 (8.4)  18 (7.7) 
p.Arg168*  8 (5.3)  11 (13.3)  19 (8.2) 
p.Arg255*  7 (4.7)  5 (6.0)  12 (5.2) 
p.Arg270*  8  (5.3)  5 (6.0)  13 (5.6) 
p.Arg294*  18  (12.0)  2 (2.4)  20 (8.6) 
p.Arg306Cys  9  (6.0)  1 (1.2)  10 (4.3) 
Other  13  (8.7)  7 (8.4)  20 (8.6) 
Negative  27  (18.0)  18 (21.7)  45 (19.3) 
Learned to walk    
Yes  96 (64.0)  18 (21.7)  114 (48.9) 
Mobility*, n (%)    
Walks normally  41 (27.3)  4 (4.8)  45 (19.3) 
Walking impaired  43 (28.7)  7 (8.4)  50 (21.5) 
Cannot walk with support  66 (44.0)  72 (86.8)   138 (59.2) 
Scoliosis*, n (%)    
None  71 (47.3)  25 (30.1)  96 (41.2) 
Mild  71 (47.3)  40 (48.2)  111 (47.6) 
Severe  4 (2.7)  8 (9.6)  12 (5.2) 
Surgically treated  4 (2.7)  10 (12.1)  14 (6.0) 
Deceased, n (%)    
Yes  17 (11.3)  30 (36.1)  47 (20.2) 
Cause of death (n=47), n (%)    
Pneumonia  5 (29.4)  9 (30.0)  14 (29.8) 
Aspiration/Aspiration pneumonia  3 (17.6)  7 (23.3)  10 (21.3) 
Respiratory failure  2 (11.8)  4 (13.3)  6 (12.8) 
Asphyxiation  1 (5.9)  2 (6.7)  3 (6.4) 
Swine influenza  0 (0)  1 (3.3)  1 (2.1) 
Others^  4 (23.5)  2 (6.7)  6 (12.8) 
Unknown  2 (11.8)  5 (16.7)  7 (14.9) 
* at time of first recorded low weight z-score 
^ cerebrovascular accident, epilepsy, status epilepticus, complications following surgery, “GI related” 
 
 
 
